Rare diseases
Investigational molecules
Locations
Back to Spain53 clinical trials in La Laguna, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma
SpainStudy on Dulaglutide for Preventing Diabetes in Patients with Metabolic Syndrome Awaiting Kidney Transplantation
SpainStudy of Giredestrant Combined with Pertuzumab-Trastuzumab (Phesgo) for Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally Advanced or Metastatic Breast Cancer
SpainStudy of Durvalumab, Olaparib, and Fulvestrant for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer with Specific Genetic Alterations
SpainStudy Comparing Lenalidomide, Bortezomib, Dexamethasone, Isatuximab, and Iberdomide for Newly Diagnosed Multiple Myeloma Patients Eligible for Stem Cell Transplant
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on breast cancer treatments, including studies of novel therapies for both HER2-positive and HR-positive variants. Research includes innovative approaches for metastatic sarcomas and lymphoma treatments.
Multiple studies evaluating targeted therapies and immunotherapies for various cancer types.
Clinical investigations examining treatments for severe asthma, allergic rhinitis, and autoimmune conditions like Sjögren's syndrome and systemic lupus erythematosus.
Focus on developing targeted immunotherapies and evaluating long-term treatment outcomes.
Studies investigating metabolic syndrome management in kidney transplant candidates and innovative approaches to prevent post-transplant diabetes. Research includes evaluation of GLP-1 receptor agonists.
Comprehensive research aimed at improving transplant outcomes and metabolic health.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
